News

  • AI helps to identify new links between the pill and lower ovarian cancer risk

    The contraceptive pill could help to reduce the risk of ovarian cancer in one in four women, AI-driven research suggests. A new study which used AI to screen for risk factors of ovarian cancer, found that the oral contraceptive pill reduced the risk of the condition by 26 per cent among women who had ever [...]

  • Research roundup: Discover the latest research and developments in fem tech

    Fem Tech World explores the latest research developments impacting on women’s health. AI system detects heart defects on foetal ultrasound exams A new study has evaluated whether an artificial intelligence (AI) system can improve the detection of congenital heart defects on foetal ultrasound exams among both general OBGYNs and maternal foetal medicine specialists. The team [...]

  • Research update: Fallopian tube findings, depression study, NHS report and more…

    Femtech World explores the latest research and developments in the world of women’s health Removing fallopian tubes may lower ovarian cancer risk A mathematical modelling study has suggested that ovarian cancer incidence could be reduced and healthcare savings boosted if women who have already completed their families were offered fallopian tube removal during any other [...]

  • Interview: On the hunt for the earliest signs of high-risk pregnancies

    Californian biotech firm Mirvie is pioneering a new approach to high risk pregnancies, by tracking a unique molecular signal associated with a leading cause of stillbirth.  Its new platform - based on RNA, the nucleic acid present in all living cells - is the first to uncover the molecular signal for babies that are at [...]

  • Reimagining women’s health with WHIS 2025

    There is an increasing recognition that investing in women’s health is both a moral and an economic imperative. Women represent half of the global population and are often the primary healthcare decision-makers for their families. Yet, historically, women's health has been underfunded and underserved in clinical research and healthcare policies. This has created gaps in [...]

  • GE aims to alleviate high risk pregnancy issues with latest release

    Global health products giant GE Healthcare has launched new AI-powered ultrasound tech which it says could improve the diagnosis and monitoring of high-risk pregnancies. The multinational has received FDA clearance in the US for the updated version of its Voluson Expert series of ultrasound systems. The tech features AI-driven functionality and tools which it says [...]

  • Period product innovation news – Egal expands as Somedays announces latest takeover

    One of New Zealand’s biggest period care brands has been acquired by Somedays, the Canadian natural period pain relief firm. AWWA Periodcare, which specialises in reusable, absorbent period underwear, was co-founded in 2018 by Michele Wilson and Kylie Matthews. It successfully delivered its mission to create a sustainable alternative to single-use menstrual products. Somedays was [...]

  • Dating app heavyweight enlisted to support femtech empire’s global rise

    A leader at the heart of the dating app revolution of recent decades has joined the board of Europe’s first femtech unicorn Flo Health. Mandy Ginsberg, former CEO of Match Group – in a role which saw her manage 12 dating app brands including Match.com, Tinder and Hinge – has been appointed to help drive [...]

  • A virtual revolution in treating chronic hormonal conditions?

    A femtech venture focused on better supporting the one in three women affected by chronic hormonal conditions has been backed by US$26m in funding. Allara Health is aiming to harness virtual care technology to address conditions such as polycystic ovarian syndrome (PCOS), endometriosis and hypothyroidism; all which can cause health challenges like infertility, high-risk pregnancies, [...]

  • Pandora’s box or the Holy Grail for fertility research? Watchdog debates IVGs

    Rapid development of the science behind in-vitro gametes (IVGs) - sperm or eggs created genetically from reprogrammed skin or stem cells - has prompted the UK's fertility watchdog to address their potential use, dangers and opportunities.  The Human Fertilisation and Embryology Authority (HFEA) has urged the UK government to consider future regulation following its latest [...]